CAS RN: 1247119-33-0
thiazol-5-ylMethyl (2R,5R)-5-aMino-1,6-diphenylhexan-2-ylcarbaMate hydrochloride
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250501
1g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1247119-33-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1247119-33-0 / 1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-amino-1,6-diphenylhexan-2-yl]carbamate;hydrochloride
Standard CAS: 1247119-33-0
Multi CAS: No
Basic Information
copy
CAS
1247119-33-0 copy
Multi CAS
No copy
Molecular Formula
C23H28ClN3O2S copy
Molecular Weight
446.000000 copy
Exact Mass
445.159076 copy
SMILES
C1=CC=C(C=C1)C[C@@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)N.Cl copy
InChI
InChI=1S/C23H27N3O2S.ClH/c24-20(13-18-7-3-1-4-8-18)11-12-21(14-19-9-5-2-6-10-19)26-23(27)28-16-22-15-25-17-29-22;/h1-10,15,17,20-21H,11-14,16,24H2,(H,26,27);1H/t20-,21-;/m1./s1 copy
InChIKey
UPZSMWCRMXVNOX-MUCZFFFMSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
30 copy
Aromatic heavy atom count
17 copy
Fraction Csp3
0.3 copy
Rotatable bonds
10 copy
H-bond acceptors
5 copy
H-bond donors
2 copy
Molar refractivity
123.97 copy
TPSA
77.24 copy
LogP / Solubility
WLOGP
4.75 copy
MLOGP
4.21 copy
XLogP3
4.75 copy
Consensus LogP
4.57 copy
Log S (ESOL)
-5.36 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-6.65 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-7.7 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.07 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3.5 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website. copy